You just read:

Spherix Global Insights' Quarterly Update on the US Migraine Prevention Market Reveals Best-In-Class Sales and Medical Affairs Support as the Driving Force Behind Teva's Ajovy Early Launch Success

News provided by

Spherix Global Insights

Mar 25, 2019, 07:50 ET